6 results
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma - Recurrence-free Survival in the
Stage III or IV Melanoma ... the Intention-to-Treat ... Population #EBM ... #Honc #Nivolumab ... #NEJM
Melanoma of the Foot - The physical examination revealed a well-defined, fleshy, reddish plaque measuring 2
Melanoma of the ... surface and black areas ... #Clinical #Derm ... #Podiatry #Honc ... #Foot #NEJM
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer - Progression-free Survival in the Intention-to-Treat Population.
the Intention-to-Treat ... #EBM #Honc #PACIFIC ... Durvalumab #NSCLC #NEJM
Upper endoscopy revealed a pigmented mass in the duodenal bulb (Panel A) and two additional masses
duodenum (Panel B) #Clinical ... #GI #Derm #Honc ... #Melanoma #Duodenum ... EGD #Metastatic #NEJM
Radiation-Induced Angiosarcoma after Breast-Cancer Treatment - Physical examination revealed an area of skin 10 cm in
Angiosarcoma after Breast-Cancer ... the dermis and breast ... #Clinical #Derm ... #Honc #Path #RadiationInducedAngiosarcoma ... Radiation #Microscopy #NEJM
Immunosuppressive Strategies for the Prevention or Treatment of Acute GVHD. Panel A shows several classic immunosuppressive
are in routine clinical ... been tested in clinical ... #Pathophysiology ... #IM #Honc #Pharm ... Immunosuppression #NEJM